Amarin Corp Plcuk (AMRN) Other Non-Current Assets (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Other Non-Current Assets of $1.0 million for Q1 2026, down 13.97% YoY from $1.2 million in Q1 2025, and down 5.34% sequentially from $1.1 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Other Non-Current Assets across 17 years of filings, most recently posting $1.0 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 13.97% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 13.97% YoY), while the FY2025 annual figure was $1.1 million, down 12.04% from the prior year.
  • Other Non-Current Assets eased to $1.0 million in Q1 2026, from $1.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for AMRN reached as high as $1.6 million in Q1 2023 and fell as low as $456000.0 in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $1.2 million (2025), against an average of $1.1 million.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 259.21% — and 2024, when it retreated 19.76%.
  • A 5-year view of Other Non-Current Assets shows it stood at $458000.0 in 2022, then jumped by 196.94% to $1.4 million in 2023, then slipped by 10.81% to $1.2 million in 2024, then slipped by 12.04% to $1.1 million in 2025, then slipped by 5.34% to $1.0 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.0 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.23 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 14.11 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 10.54 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 19.81 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.76 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 4.55 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 9.83 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 200.00 Mn
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 1.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.01 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 1.11 Mn
Jun 30, 2025 1.14 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.21 Mn
Sep 30, 2024 1.25 Mn
Jun 30, 2024 1.29 Mn
Mar 31, 2024 1.32 Mn
Dec 31, 2023 1.36 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.60 Mn
Mar 31, 2023 1.64 Mn
Dec 31, 2022 458,000.00
Sep 30, 2022 456,000.00
Jun 30, 2022 456,000.00
Mar 31, 2022 456,000.00
Dec 31, 2021 456,000.00
Sep 30, 2021 456,000.00
Jun 30, 2021 456,000.00